The submission represents Eli Lilly, a massive pharmaceutical entity with verifiable market traction exceeding $700B and global reach. While the project demonstrates exceptional Real-World Utility and Evidence of Traction due to its scale and essential healthcare products, the submission quality is low ('DeepGale', generic tags). The score reflects the immense value and established nature of the business, adjusted for the lack of specific technical detail and current market context (e.g., GLP-1 agonists) in the text provided.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline